Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.

Human reproduction (Oxford, England) - 1 May 1999

Murray A, Webb J, MacSwiney F, Shipley E L, Morton N E, Conway G S

Abstract excerpt

It is now recognized that female carriers of fragile X premutations are at increased risk of premature ovarian failure. We have studied 51 premenopausal women from fragile X families, to determine whether premutation carriers have variations in the hormonal markers of menopause, compared to full...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Follicle Stimulating Hormone
Share to Fragile X Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Carrier Screening

Share to Mutation

Share to Predictive Value of Tests

Share to Premenopause

Share to Primary Ovarian Insufficiency

Source

Open in PubMed Open full text

Identifiers

PMID: 10325264
DOI: 10.1093/humrep/14.5.1217
PMCID: PMC3728645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-10325264-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.PMID 10325264Read ↗

Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.Semantic proximity Read ↗

Reproductive and menstrual history of females with fragile X expansions.Semantic proximity Read ↗

Premature ovarian failure and FRAXA premutation: Positive correlation in a Brazilian survey.Semantic proximity Read ↗

Premature ovarian failure and FMR1 gene mutations: an update.Semantic proximity Read ↗

Fragile X premutation screening in women with premature ovarian failure.Semantic proximity Read ↗

Premature ovarian failure and fragile X premutation: a study on 45 women.Semantic proximity Read ↗

Fragile X premutation in women with sporadic premature ovarian failure in Slovenia.Semantic proximity Read ↗

Premature ovarian failure in the fragile X syndrome.Semantic proximity Read ↗

FRAXA premutation associated with premature ovarian failure.Semantic proximity Read ↗

Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.Semantic proximity Read ↗

Evidence of early ovarian aging in fragile X premutation carriers.Semantic proximity Read ↗

Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.